Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

74 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    The European Commission Authorises German SGEI Compensation Of EUR 400 Million In Favour Of Sanofi For The Supply Of Insulin

    The European Commission has authorized EUR 400 million in German State aid to Sanofi to secure insulin supply within the EEA, marking a significant development in European pharmaceutical policy.
    GermanyGovernment, Public Sector
    CMS Wistrand
    CMS Wistrand
  • Article

    Wind Of Change - Are Medical Sick Leave Certificates Still Untouchable?

    High sickness rates present significant challenges for employers. Previously, if employers had doubts about an employee's actual incapacity for work, they faced significant challenges due to the high probative value of the certificate of incapacity for work.
    GermanyFood, Drugs, Healthcare, Life Sciences
Littler
Littler
  • Article

    Health Data: European Commission Proposes New Rules On Access And Use

    In May 2022, the European Commission published a proposal to establish a European Health Data Space ("EHDS"). The Commission's EHDS proposal aims to improve access by individuals to their health data...
    European UnionIntellectual Property
    Mayer Brown
    Mayer Brown
  • Article

    Expected Amendments Of The Medical Device Regulation Will Most Likely Increase The Attractiveness Of Investments In The Sector

    Investments in the health care sector are very popular since the start of the COVID-19 pandemic. In Germany, there has been a particular interest in the strong German medical technology sector...
    GermanyFood, Drugs, Healthcare, Life Sciences
    Oppenhoff
    Oppenhoff
  • Article

    German Federal Patent Court Grants Compulsory License On HIV Drug Patent

    On 31 August 2016, the German Federal Patent Court issued a compulsory license under a patent that protects an HIV drug to affiliates of Merck & Co. (case number 3 LiQ 1/16).
    GermanyIntellectual Property
    Mayer Brown
    Mayer Brown
  • Article

    State Aid Rules And COVID-19 (Coronavirus) In The EU

    To mitigate the economic repercussions of the COVID-19 outbreak in the Member States, authorities are considering support measures ...
    European UnionCorporate/Commercial Law
    Dentons
    Dentons
  • Article

    The Federal Supreme Court And “The Sword Of Damocles Of Termination“

    New judgement of the Federal Supreme Court with regard to the maximum duration of the right of termination granted to the senior partners vis-à-vis a newly entered partner in joint practice contracts.
    GermanyFood, Drugs, Healthcare, Life Sciences
    FPS RECHTSANWALTE & NOTARE
    FPS RECHTSANWALTE & NOTARE
  • Article

    Untransparent Law - Translucent Food Producers? The Coming German Food and Feed Act

    The legislative process towards a new German Food and Feed Act (Lebensmittel- und Futtermittelgesetzbuch - <B>LFGB</B>) has entered into the next round: ignoring several objections by the Federal Council (Bundesrat), the German Parliament (Bundestag) approved the bill for the LFGB at the end of November 2004.
    GermanyFood, Drugs, Healthcare, Life Sciences
    Lovells
    Lovells
  • Article

    German Government Expands Authority Over Takeovers By Investors From Outside The EU

    On July 18, 2017, the German government enacted changes to the Foreign Trade and Payments Ordinance ("AWV") that significantly expand the scope of the law.
    GermanyGovernment, Public Sector
    Jones Day
    Jones Day
  • Article

    Coronavirus And Insurance Cover

    The coronavirus is currently causing a lot of uproar. Many companies are reviewing their risks in case of infection or are trying to mitigate damage caused by canceled events and trade shows.
    GermanyInsurance
    HEUKING
    HEUKING
  • Article

    EU Commission Consultation On High-Risk AI Systems: Key Points For Life Sciences And Health Care

    On 6 June 2025, the European Commission launched a targeted stakeholder consultation on the classification and regulation of high-risk artificial intelligence (AI) systems under the EU Artificial Intelligence Act (AI Act).
    European UnionFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    EU MDR And IVDR Implementation: New Transitional Regime Enters Into Force

    On March 20, 2023, the new transitional regime for medical devices in the EU and the EEA became effective when Regulation (EU) 2023/607 (the "Regulation")...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Morrison Foerster
    Morrison Foerster
  • Article

    Corona-Impfung Für Arbeitnehmer: Wer Trägt Die Kosten Und Ist Eine Impfung Verpflichtend?

    Ein Impfstoff gegen Sars-CoV-2 (das „Corona-Virus") wird kommen – aller Voraussicht nach in absehbarer Zeit.
    GermanyCoronavirus (COVID-19)
    Mayer Brown
    Mayer Brown
  • Article

    Methods of Treatment in Europe: Patent Claims Covering Second or Further Medical Uses and Dosage Regimens

    The decision G 2/08 of February 19, 2010 (published October 28, 2010) of the Enlarged Board of Appeal (EBA) of the European Patent Office confirms that a substance or composition known as a medicament for treating a certain illness can be patented for use in a different treatment by therapy of the same disease.
    GermanyIntellectual Property
    Jones Day
    Jones Day
  • Article

    Bundesgerichtshof setzt neue Maßstäbe bei der Einschränkung von EU-Freiheiten in Zivilverfahren

    Der Bundesgerichtshof (BGH) hat in einer Grundsatzentscheidung (I ZR 74/24 – Arzneimittel-Check) entschieden, dass nationale Gerichte auch in Streitigkeiten zwischen privaten...
    GermanyFood, Drugs, Healthcare, Life Sciences
    Greenberg Traurig
    Greenberg Traurig
  • Article

    So Bereiten Sich Arbeitgeber Auf Die Elektronische Arbeitsunfähigkeitsbescheinigung Vor

    Am 1. Januar 2023 ist es so weit – die elektronische AU-Bescheinigung kommt (endlich) auch ins Unternehmen. Bislang waren lediglich Ärztinnen und Ärzte verpflichtet, die Daten zur AU-Bescheinigung...
    GermanyEmployment and HR
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    New German Government: Key Plans For The Life Sciences And Healthcare Sector

    Following the election in February, the party leaderships of CDU, CSU and SPD have agreed on a coalition agreement titled "Responsibility for Germany".
    GermanyFood, Drugs, Healthcare, Life Sciences
    A&O Shearman
    A&O Shearman
  • Article

    Konsultation der EU-Kommission zu Hochrisiko-KI-Systemen: Kernpunkte für den Life Sciences- und Health Care-Sektor

    Am 6. Juni 2025 hat die Europäische Kommission eine Konsultation zur Einstufung und Regulierung von Hochrisiko-KI-Systemen im Rahmen der...
    GermanyTechnology
    Greenberg Traurig
    Greenberg Traurig
  • Article

    "All Or Nothing” Or Only In Part? – What The Proposed Concept Of Partial Incapacity For Work Entails Under German Law

    With the recently announced healthcare reform, the German Federal Government intends, for the first time, to codify the concept of so-called partial incapacity for work.
    GermanyEmployment and HR
    Littler Mendelson
    Littler Mendelson
  • Article

    New Value-Based Filing Thresholds In European Merger Control Regimes – Implications For Healthcare And Life Sciences Companies

    Germany and Austria recently introduced new alternative merger control thresholds based on transaction value. At EU level the introduction of a value-based filing threshold is also being discussed.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Baker McKenzie
    Baker McKenzie
  • Showing 21–40 of 74 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics